These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34924308)

  • 1. Antibody responses to SARS-CoV-2 nucleocapsid and spike proteins in hospitalized patients with COVID-19: A multicenter, retrospective, cross-sectional study in Japan.
    Hibino M; Watanabe S; Tobe S; Maeda K; Horiuchi S; Nishiguchi S; Iwase A; Uryu K; Kobayashi S; Kondo T
    Respir Investig; 2022 Mar; 60(2):256-263. PubMed ID: 34924308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays.
    Shah J; Liu S; Potula HH; Bhargava P; Cruz I; Force D; Bazerbashi A; Ramasamy R
    BMC Infect Dis; 2021 Apr; 21(1):325. PubMed ID: 33827460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Measurement of IgM and IgG Antibodies to SARS-CoV-2 Spike, RBD, and Nucleocapsid Multiplexed in a Single Assay on the xMAP INTELLIFLEX DR-SE Flow Analyzer.
    Cameron A; Bohrhunter JL; Porterfield CA; Mangat R; Karasick MH; Pearson Z; Angeloni S; Pecora ND
    Microbiol Spectr; 2022 Apr; 10(2):e0250721. PubMed ID: 35389244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
    Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
    Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of ELISA Using Total Antibody against Plant-Expressed Recombinant Nucleocapsid Protein of SARS-CoV-2.
    Tariq M; Hur J; Seo JW; Kim DY; Yun NR; Lee YM; Bang MS; Hwang SY; Kim CM; Lee JH; Song KH; Lee H; Jung J; Park JY; Kim HB; Kim ES; Lee S; Kim DM
    Microbiol Spectr; 2021 Dec; 9(3):e0067221. PubMed ID: 34817278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2.
    Liu W; Liu L; Kou G; Zheng Y; Ding Y; Ni W; Wang Q; Tan L; Wu W; Tang S; Xiong Z; Zheng S
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32229605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.
    Al-Mughales JA; Al-Mughales TJ; Saadah OI
    Front Immunol; 2021; 12():705441. PubMed ID: 34539635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
    Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of six SARS-CoV-2 serology assays: Diagnostic performance and antibody dynamics in a cohort of hospitalized patients for moderate to critical COVID-19.
    Chamkhi S; Dhaouadi T; Sfar I; Mokni S; Jebri A; Mansouri D; Ghedira S; Ben Jemia E; Ben Boujemaa S; Houissa M; Aouina H; Ben Abdallah T; Gorgi Y
    Int J Immunopathol Pharmacol; 2022; 36():20587384211073232. PubMed ID: 35113728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing Immunoassays for SARS-CoV-2 Antibody Detection in Patients with and without Laboratory-Confirmed SARS-CoV-2 Infection.
    Leuzinger K; Osthoff M; Dräger S; Pargger H; Siegemund M; Bassetti S; Bingisser R; Nickel CH; Tschudin-Sutter S; Khanna N; Rentsch K; Battegay M; Egli A; Hirsch HH
    J Clin Microbiol; 2021 Nov; 59(12):e0138121. PubMed ID: 34524886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of SARS-CoV-2 IgG assays against nucleocapsid and spike antigens.
    Rezaei M; Sadeghi M; Korourian A; Tabarsi P; Porabdollah M; Askari E; Mortaz E; Mahmoudi S; Marjani M; Velayati AA
    Hum Antibodies; 2021; 29(2):109-113. PubMed ID: 33720878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different long-term avidity maturation for IgG anti-spike and anti-nucleocapsid SARS-CoV-2 in hospitalized COVID-19 patients.
    Heireman L; Boelens J; Coorevits L; Verhasselt B; Vandendriessche S; Padalko E
    Acta Clin Belg; 2022 Jun; 77(3):653-657. PubMed ID: 34152944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies.
    Takahashi M; Ai T; Sinozuka K; Baba Y; Igawa G; Nojiri S; Yamamoto T; Yuri M; Takei S; Saito K; Horiuchi Y; Kanno T; Tobiume M; Khasawneh A; Paran FJ; Hiki M; Wakita M; Miida T; Suzuki T; Okuzawa A; Takahashi K; Naito T; Tabe Y
    Sci Rep; 2022 Sep; 12(1):14909. PubMed ID: 36050347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Evaluation of the Abbott Alinity SARS-CoV-2 Spike-Specific Quantitative IgG and IgM Assays among Infected, Recovered, and Vaccinated Groups.
    Narasimhan M; Mahimainathan L; Araj E; Clark AE; Markantonis J; Green A; Xu J; SoRelle JA; Alexis C; Fankhauser K; Parikh H; Wilkinson K; Reczek A; Kopplin N; Yekkaluri S; Balani J; Thomas A; Singal AG; Sarode R; Muthukumar A
    J Clin Microbiol; 2021 Jun; 59(7):e0038821. PubMed ID: 33827901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.
    Zhou C; Bu G; Sun Y; Ren C; Qu M; Gao Y; Zhu Y; Wang L; Sun L; Liu Y
    J Med Virol; 2021 May; 93(5):2857-2866. PubMed ID: 33331654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19.
    Flinck H; Rauhio A; Luukinen B; Lehtimäki T; Haapala AM; Seiskari T; Aittoniemi J
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115197. PubMed ID: 32977117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.